High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia

This publication has 24 references indexed in Scilit:

• Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients
  Bone Marrow Transplantation, 1999
• Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience
  Bone Marrow Transplantation, 1998
• High CD34+ Cell Counts Decrease Hematologic Toxicity of Autologous Peripheral Blood Progenitor Cell Transplantation
  Blood, 1998
• A Multicenter Study of Platelet Recovery and Utilization in Patients After Myeloablative Therapy and Hematopoietic Stem Cell Transplantation
  Blood, 1998
• Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients
  Bone Marrow Transplantation, 1997
• Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 1997
• Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
  The Lancet, 1996
• Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.
  Journal of Clinical Oncology, 1995
• Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.
  Journal of Clinical Oncology, 1995
• Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma
  Blood, 1994